UCL spin out Odin Vision acquired by Olympus to supercharge global growth

Odin Vision - Odin Vision Odin Vision, a UCL spin out company that develops pioneering AI-driven endoscopy technology to help better detect cancers, has been acquired by Olympus Corporation (Olympus) for up to £66 million. The company, spun out of research led by UCL scientists, is a world-leading pioneer of cloud AI-enabled applications for endoscopy, which enables clinicians to detect some early stage colorectal and oesophageal cancers. It was launched in 2019 with the support of B usiness (UCLB) , that helps academic entrepreneurs to commercialise IP , in the form of new businesses. The acquisition deal will see Olympus acquire Odin's entire portfolio of award-winning AI solutions, enabling Odin's life-saving tools to reach millions of new patients around the world. Commenting Peter Mountney, CEO of Odin Vision and Honorary Associate Professor at UCL Computer Science, said: "I'm incredibly proud of the team. We started with a university research project at UCL and transformed it into a commercial healthcare technology that will help millions around the world in the fight against cancer." Odin Vision began with the research of Patrick Brandão, Professor Danail Stoyanov and Professor Laurence Lovat, based at the UCL Wellcome / EPSRC Centre for Interventional and Surgical Sciences. Their pioneering work developed polyp detection systems which assisted doctors in the detection of colorectal cancer.